Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

BridgeBio Pharma Secures $200M Private Financing to Propel Oncology Portfolio Development

Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round for its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (BBOT), aiming to strengthen its oncology portfolio. Led by Cormorant Asset Management and co-led by Omega Funds, the oversubscribed financing reflects confidence from investors like Deerfield Management, GV, EcoR1 Capital, and others. This funding infusion is intended to accelerate BridgeBio's oncology initiatives, furthering its mission to address genetic diseases and cancers.

Read full article here.

Recent Posts

See All

Brian Blaser appointed as QuidelOrtho's President and CEO

San Diego, CA, May 2, 2024 (QuidelOrtho) -- Brian J. Blaser has been appointed as the new President and CEO of QuidelOrtho. Most recently overseeing Abbott's global diagnostics organization, he brin

Novartis to buy Mariana Oncology for $1B upfront

Watertown, MA, May 2, 2024 (finance.yahoo.com) -- Novartis is acquiring Mariana Oncology, a biotech firm specializing in targeted radiation medicines, for $1 billion. Mariana could receive up to $75

Cagent Vascular appoints Brian Walsh as CEO

Wayne, PA, May 7, 2024 (Business Wire) -- Brian Walsh, previously at Carl Zeiss, has been appointed as the new Chief Executive Officer at Cagent Vascular. His extensive experience in the medical dev

BridgeBio Pharma Secures $200M Private Financing to Propel Oncology Portfolio Development

Brian Blaser appointed as QuidelOrtho's President and CEO

Novartis to buy Mariana Oncology for $1B upfront

Cagent Vascular appoints Brian Walsh as CEO

ONO Pharmaceutical to Acquire Deciphera Pharmaceuticals in $2.4B Deal

Weight-Loss Drug Startup Metsera Launches with $290M Funding

Flare Therapeutics Names Dr. Douglas Manion as New CEO

Incyte Corp. to Acquire Escient Pharmaceuticals for $750M

Biopharmaceutical Leader Thomas Smart Takes Helm as CEO at Actym Therapeutics

Steris Sells Dental Segment to Peak Rock affiliate in $787M Deal

Executive Spotlights

BridgeBio Pharma Secures $200M Private Financing to Propel Oncology Portfolio Development

Recent Posts

Life Science Headlines